| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |